argenx Management
Management criteria checks 2/4
argenx's CEO is Tim Van Hauwermeiren, appointed in Apr 2008, has a tenure of 16.17 years. total yearly compensation is $11.94M, comprised of 5.5% salary and 94.5% bonuses, including company stock and options. directly owns 0.19% of the company’s shares, worth €39.45M. The average tenure of the management team and the board of directors is 2.3 years and 7.2 years respectively.
Key information
Tim Van Hauwermeiren
Chief executive officer
US$11.9m
Total compensation
| CEO salary percentage | 5.5% |
| CEO tenure | 16.2yrs |
| CEO ownership | 0.2% |
| Management average tenure | 2.3yrs |
| Board average tenure | 7.2yrs |
Recent management updates
Recent updates
argenx SE's (EBR:ARGX) CEO Looks Like They Deserve Their Pay Packet
May 01
Investors Appear Satisfied With argenx SE's (EBR:ARGX) Prospects
Apr 11Analyst Estimates: Here's What Brokers Think Of argenx SE (EBR:ARGX) After Its Yearly Report
Mar 24Analysts Have Made A Financial Statement On argenx SE's (EBR:ARGX) Full-Year Report
Mar 05argenx SE (EBR:ARGX) Shares Could Be 24% Below Their Intrinsic Value Estimate
Feb 23Getting In Cheap On argenx SE (EBR:ARGX) Is Unlikely
Dec 18Broker Revenue Forecasts For argenx SE (EBR:ARGX) Are Surging Higher
Jul 28An Intrinsic Calculation For argenx SE (EBR:ARGX) Suggests It's 31% Undervalued
Jul 17Revenues Tell The Story For argenx SE (EBR:ARGX)
Jun 20argenx (EBR:ARGX) Is Using Debt Safely
May 08We Think argenx (EBR:ARGX) Can Afford To Drive Business Growth
Apr 20Does argenx (EBR:ARGX) Have A Healthy Balance Sheet?
Dec 27We're Not Very Worried About argenx's (EBR:ARGX) Cash Burn Rate
Oct 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$328m |
| Dec 31 2023 | US$12m | US$656k | -US$295m |
| Sep 30 2023 | n/a | n/a | -US$234m |
| Jun 30 2023 | n/a | n/a | -US$397m |
| Mar 31 2023 | n/a | n/a | -US$511m |
| Dec 31 2022 | US$8m | US$639k | -US$710m |
| Sep 30 2022 | n/a | n/a | -US$909m |
| Jun 30 2022 | n/a | n/a | -US$907m |
| Mar 31 2022 | n/a | n/a | -US$595m |
| Dec 31 2021 | US$7m | US$652k | -US$408m |
| Sep 30 2021 | n/a | n/a | -US$373m |
| Jun 30 2021 | n/a | n/a | -US$319m |
| Mar 31 2021 | n/a | n/a | -US$573m |
| Dec 31 2020 | US$9m | US$641k | -US$608m |
| Sep 30 2020 | n/a | n/a | -US$535m |
| Jun 30 2020 | n/a | n/a | -US$359m |
| Mar 31 2020 | n/a | n/a | -US$275m |
| Dec 31 2019 | US$7m | US$589k | -US$181m |
| Sep 30 2019 | n/a | n/a | -US$109m |
| Jun 30 2019 | n/a | n/a | -US$104m |
| Mar 31 2019 | n/a | n/a | -US$47m |
| Dec 31 2018 | US$5m | US$573k | -US$76m |
| Sep 30 2018 | n/a | n/a | -US$56m |
| Jun 30 2018 | n/a | n/a | -US$47m |
| Mar 31 2018 | n/a | n/a | -US$46m |
| Dec 31 2017 | US$4m | US$365k | -US$34m |
Compensation vs Market: Tim's total compensation ($USD11.94M) is above average for companies of similar size in the Belgian market ($USD3.37M).
Compensation vs Earnings: Tim's compensation has increased whilst the company is unprofitable.
CEO
Tim Van Hauwermeiren (52 yo)
16.2yrs
Tenure
US$11,944,835
Compensation
Mr. Timothy Van Hauwermeiren, also known as Tim, MSc, EMBA, has been Independent Director at iTeos Therapeutics, Inc. since June 2018. Mr. Van Hauwermeiren has general management and business development e...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 16.2yrs | US$11.94m | 0.19% $ 39.5m | |
| Chief Financial Officer | 3yrs | US$4.76m | 0.0050% $ 1.1m | |
| Chief Operating Officer | 1.3yrs | US$7.65m | no data | |
| VP & Global Head of Technical Operations | 2.2yrs | no data | no data | |
| Chief Scientific Officer | 1.4yrs | no data | 0.00087% $ 185.5k | |
| VP and Global Head of Corporate Communications & Investor Relations | 2.2yrs | no data | no data | |
| General Counsel | 2.3yrs | no data | 0% $ 0 | |
| Vice President of Corporate Development & Strategy | 5yrs | no data | 0.0021% $ 439.1k | |
| Global Head of Human Resources | 5.5yrs | no data | no data | |
| Global Head of Quality | 4.4yrs | no data | 0.00050% $ 106.6k | |
| Chief Medical Officer | 2.2yrs | no data | 0.0027% $ 584.1k |
2.3yrs
Average Tenure
52yo
Average Age
Experienced Management: ARGX's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 9.9yrs | US$11.94m | 0.19% $ 39.5m | |
| Independent Vice-Chairman of the Board | 9.1yrs | US$482.23k | 0.00076% $ 162.0k | |
| Independent Chairman of the Board | 9.9yrs | US$660.33k | 0.00076% $ 162.0k | |
| Independent Non-Executive Director | 7.2yrs | US$476.82k | 0.00076% $ 162.0k | |
| Independent Non-Executive Director | 6.1yrs | US$482.23k | 0.00076% $ 162.0k | |
| Independent Non-Executive Director | 8.2yrs | US$471.41k | 0.00076% $ 162.0k | |
| Member of Board Advisors | no data | no data | 0.62% $ 132.6m | |
| Member of Board Advisors | no data | US$622.58k | no data | |
| Independent Non-Executive Director | 1.3yrs | US$635.65k | 0.00022% $ 46.9k | |
| Independent Non-Executive Director | 1.8yrs | US$365.24k | 0.00038% $ 81.0k | |
| Member of Board Advisors | 1.3yrs | US$656.08k | 0.0056% $ 1.2m | |
| Member of Board Advisors | no data | no data | no data |
7.2yrs
Average Tenure
63.5yo
Average Age
Experienced Board: ARGX's board of directors are considered experienced (7.2 years average tenure).